Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Among HIV-infected Adults
Conditions: Streptococcal Pneumonia; HIV/AIDS Intervention: Biological: Prevenar13 Sponsor: Korea University Guro Hospital Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: AIDS Vaccine | HIV AIDS | Hospitals | Meningitis Vaccine | Pneomococcal Vaccine | Pneumonia | Research | Vaccines